Interestingly, because adiponectin is secreted mostly by subcutaneous fat rather than visceral fat, hypoadiponectinemia may also help to explain why patients with central obesity more commonly develop insulin resistance among patients with NAFLD [30] (Table 1). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.